{
    "Trade/Device Name(s)": [
        "NEPHROCHECK Test System"
    ],
    "Submitter Information": "Astute Medical, Inc.",
    "510(k) Number": "K153165",
    "Predicate Device Reference 510(k) Number(s)": [
        "DEN130031",
        "K131650"
    ],
    "Regulatory Class": "Class II",
    "Product Code(s)": [
        "PIG"
    ],
    "Summary Letter Date": "May 3, 2016",
    "Summary Letter Received Date": "May 3, 2016",
    "Submission Date": "May 13, 2016",
    "Regulation Number(s)": [
        "21 CFR 862.1220"
    ],
    "Regulation Name(s)": [
        "Acute Kidney Injury Test System"
    ],
    "Analyte Class(es)": [
        "chemistry",
        "toxicology"
    ],
    "Analyte(s)": [
        "Insulin-like growth factor-binding protein 7 (IGFBP7)",
        "Tissue inhibitor of metalloproteinases 2 (TIMP-2)"
    ],
    "Specimen Type(s)": [
        "Urine"
    ],
    "Specimen Container(s)": [
        ""
    ],
    "Instrument(s)/Platform(s)": [
        "ASTUTE 140 Meter"
    ],
    "Method(s)/Technology(ies)": [
        "Immunoassay",
        "Fluorescent detection"
    ],
    "Methodologies": [
        "Protein biomarker detection"
    ],
    "Submission Type(s)": [
        "Test",
        "Kit",
        "Analyzer",
        "Control",
        "Calibration Verification Kit"
    ],
    "Document Summary": "FDA 510(k) summary for Astute Medical NEPHROCHECK Test System, a fluorescent immunoassay for IGFBP7 and TIMP-2 to assess risk of moderate/severe acute kidney injury in ICU patients.",
    "Indications for Use Summary": "Aid in risk assessment for moderate or severe acute kidney injury within 12 hours in adult ICU patients (21+ years) with recent acute cardiovascular or respiratory compromise, used in conjunction with clinical evaluation.",
    "fda_folder": "Clinical Chemistry"
}